Atlas Trials

Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

Clinical trial NCT02851797 · COMPLETED

Trial details

NCT number
NCT02851797
Sponsor
Italfarmaco
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2017-06-06
Primary completion
2022-02-22
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.